Blending Math With Beauty

Question: What was the discovery process behind the Mandelbrot set?

Benoit Mandelbrot: The Mandelbrot set in a certain sense is a **** of a dream I had and an uncle of mine had since I was about 20.  I was a student of mathematics, but not happy with mathematics that I was taught in France.  Therefore, looking for other topics, an uncle of mine, who was a very well-known pure mathematician, wanted me to study a certain theory which was then many years old, 30 years old or something, but had in a way stopped developing.  When he was young he had tried to get this theory out of a rut and he didn’t succeed, nobody succeeded.  So, there was a case of two men, Julia, a teacher of mine, and Fatu, who had died, had a very good year in 1910 and then nothing was happening.  My uncle was telling me, if you look at that, if you find something new, it would be a wonderful thing because I couldn’t – nobody could. 

I looked at it and found it too difficult.  I just could see nothing I could do.  Then over the years, I put that a bit in the back of my mind until one day I read an obituary.  It is an interesting story that I was motivated by an obituary, an obituary of a great man named Poincaré, and in that obituary this question was raised again.  At that time, I had a computer and I had become quite an expert in the use of the computer for mathematics, for physics, and for many sciences.  So, I decided, perhaps the time has come to please my uncle; 35 years later, or something.  To please my uncle and do what my uncle had been pushing me to do so strongly.  

But I approached this topic in a very different fashion than my uncle.  My uncle was trying to think of something, a new idea, a new problem, a new way of developing the theory of Fatu and Julia.  I did something else.  I went to the computer and tried to experiment.  I introduced a very high level of experiment in very pure mathematics.  I was at IBM, I had the run of computers which then were called very big and powerful, but in fact were less powerful than a handheld machine today.  But I had them and I could make the experiments.  The conditions were very, very difficult, but I knew how to look at pictures.  In fact, the reason I did not go into pure mathematics earlier was that I was dominated by visual.  I tried to combine the visual beauty and the mathematics. 

So, I looked at the picture for a long time in a very unsystematic fashion just to become acquainted in a kind of physical fashion with those extraordinary difficult and complicated shapes.  Two were extraordinarily difficult.  Computer graphics did not exist back then, but to have a machine which was – made it seem doable.  And I started finding extraordinary complications, extraordinary structure, extraordinary beauty of both a theoretical kind, mathematical, and a visual kind.  And collected observations of my trip in this new territory.  When I presented that work to my colleagues, it was an explosion of interest.  Everybody in mathematics had given up for 100 years or 200 years the idea that you could from pictures, from looking at pictures, find new ideas.  That was the case long ago in the Middle Ages, in the Renaissance, in later periods, but then mathematicians had become very abstract.  Pictures were completely eliminated from mathematics; in particular when I was young this happened in a very strong fashion. 

Some mathematicians didn’t even perceive of the possibility of a picture being helpful.  To the contrary, I went into an orgy of looking at pictures by the hundreds; the machines became a little bit better.  We had friends who improved them, who wrote better software to help me, which was wonderful.  That was the good thing about being at IBM.  And I had this collection of observations, which I gave to my friends in mathematics for their pleasure and for simulation.  The extraordinary fact is that the first idea I had which motivated me, that worked, is conjecture, a mathematical idea which may or may not be true.  And that idea is still unproven.  It is the foundation, what started me and what everybody failed to **** prove has so far defeated the greatest efforts by experts to be proven.  In a certain sense it’s a very, very strange because the object itself is understandable, even for a child.  If the object can be drawn by a child with new computers, with new graphic devices, and still the basic idea has not been proven. 

But the development of it has been extraordinary, then it was slowed down a bit, and now again it is going up.  New people are coming in and they prove extraordinary results which nobody was hoping to prove, and I am astonished and of course, very pleased by this development.

Question: What is the unproven conjecture that drove you?

Benoit Mandelbrot: The conjecture itself consists in two different issues in Mandelbrot set – two alternative definitions which are too technical to describe without a blackboard, but which are both very simple and which I assumed naively to be equivalent.  Why did I assume so?  Because on the pictures I could not see any difference.  Obtaining pictures in one way or another way, I couldn’t tell them apart.  Therefore, I assumed they were identical and I went on studying this piece.  I found that, again, many interesting observations of which most were very preferred by many other very, very skilled mathematicians.  But the idea that these two conditions, definitions, are identical is still open.  So there are two definitions in Mandelbrot set, the usual one and another one, and they may theoretically be different.  People are getting closer, but have not proven it completely.

Recorded on February 17, 2010
Interviewed by Austin \r\nAllen

\r\n

How a quest to combine aesthetics with mathematics produced one of math’s most famous, and gorgeous, images: the Mandelbrot set.

Why so gassy? Mysterious methane detected on Saturn’s moon

Scientists do not know what is causing the overabundance of the gas.

Credit: NASA
Surprising Science
  • A new study looked to understand the source of methane on Saturn's moon Enceladus.
  • The scientists used computer models with data from the Cassini spacecraft.
  • The explanation could lie in alien organisms or non-biological processes.
Keep reading Show less

CRISPR therapy cures first genetic disorder inside the body

It marks a breakthrough in using gene editing to treat diseases.

Credit: National Cancer Institute via Unsplash
Technology & Innovation

This article was originally published by our sister site, Freethink.

For the first time, researchers appear to have effectively treated a genetic disorder by directly injecting a CRISPR therapy into patients' bloodstreams — overcoming one of the biggest hurdles to curing diseases with the gene editing technology.

The therapy appears to be astonishingly effective, editing nearly every cell in the liver to stop a disease-causing mutation.

The challenge: CRISPR gives us the ability to correct genetic mutations, and given that such mutations are responsible for more than 6,000 human diseases, the tech has the potential to dramatically improve human health.

One way to use CRISPR to treat diseases is to remove affected cells from a patient, edit out the mutation in the lab, and place the cells back in the body to replicate — that's how one team functionally cured people with the blood disorder sickle cell anemia, editing and then infusing bone marrow cells.

Bone marrow is a special case, though, and many mutations cause disease in organs that are harder to fix.

Another option is to insert the CRISPR system itself into the body so that it can make edits directly in the affected organs (that's only been attempted once, in an ongoing study in which people had a CRISPR therapy injected into their eyes to treat a rare vision disorder).

Injecting a CRISPR therapy right into the bloodstream has been a problem, though, because the therapy has to find the right cells to edit. An inherited mutation will be in the DNA of every cell of your body, but if it only causes disease in the liver, you don't want your therapy being used up in the pancreas or kidneys.

A new CRISPR therapy: Now, researchers from Intellia Therapeutics and Regeneron Pharmaceuticals have demonstrated for the first time that a CRISPR therapy delivered into the bloodstream can travel to desired tissues to make edits.

We can overcome one of the biggest challenges with applying CRISPR clinically.

—JENNIFER DOUDNA

"This is a major milestone for patients," Jennifer Doudna, co-developer of CRISPR, who wasn't involved in the trial, told NPR.

"While these are early data, they show us that we can overcome one of the biggest challenges with applying CRISPR clinically so far, which is being able to deliver it systemically and get it to the right place," she continued.

What they did: During a phase 1 clinical trial, Intellia researchers injected a CRISPR therapy dubbed NTLA-2001 into the bloodstreams of six people with a rare, potentially fatal genetic disorder called transthyretin amyloidosis.

The livers of people with transthyretin amyloidosis produce a destructive protein, and the CRISPR therapy was designed to target the gene that makes the protein and halt its production. After just one injection of NTLA-2001, the three patients given a higher dose saw their levels of the protein drop by 80% to 96%.

A better option: The CRISPR therapy produced only mild adverse effects and did lower the protein levels, but we don't know yet if the effect will be permanent. It'll also be a few months before we know if the therapy can alleviate the symptoms of transthyretin amyloidosis.

This is a wonderful day for the future of gene-editing as a medicine.

—FYODOR URNOV

If everything goes as hoped, though, NTLA-2001 could one day offer a better treatment option for transthyretin amyloidosis than a currently approved medication, patisiran, which only reduces toxic protein levels by 81% and must be injected regularly.

Looking ahead: Even more exciting than NTLA-2001's potential impact on transthyretin amyloidosis, though, is the knowledge that we may be able to use CRISPR injections to treat other genetic disorders that are difficult to target directly, such as heart or brain diseases.

"This is a wonderful day for the future of gene-editing as a medicine," Fyodor Urnov, a UC Berkeley professor of genetics, who wasn't involved in the trial, told NPR. "We as a species are watching this remarkable new show called: our gene-edited future."

Android has won the phone world war

A global survey shows the majority of countries favor Android over iPhone.

Credit: Electronics Hub
Strange Maps
  • When Android was launched soon after Apple's own iPhone, Steve Jobs threatened to "destroy" it.
  • Ever since, and across the world, the rivalry between both systems has animated users.
  • Now the results are in: worldwide, consumers clearly prefer one side — and it's not Steve Jobs'.
Keep reading Show less

UFOs: US intelligence report finds no aliens but plenty of unidentified flying objects

A new government report describes 144 sightings of unidentified aerial phenomena.

Photo by Albert Antony on Unsplash
Surprising Science

On June 25, 2021, the Office of the Director of National Intelligence released a much-anticipated report on UFOs to Congress.

Keep reading Show less
Quantcast